Deep brain stimulation (DBS) of the subthalamic nucleus (STN) or globus pallidum internus
(GPi) improves motor functions in patients with Parkinson's disease (PD) but may cause a …

Adequate food intake and relative abundance of dietary nutrients have undisputed effects on
the brain function. There is now substantial evidence that dietary nutrition aids in the …

The neurosurgical treatment of movement disorders, primarily via deep brain stimulation
(DBS), is a rapidly expanding and evolving field. Although conventional targets including the …

Neurodegenerative diseases are a collection of disorders that result in the progressive
degeneration and death of neurons. They are clinically heterogenous and can present as …

Aims The effects of subthalamic nucleus (STN)‐deep brain stimulation (DBS) on brain
topological metrics, functional connectivity (FC), and white matter integrity were studied in …

Parkinson's Disease (PD) is a progressive degenerative disease characterized by tremor,
bradykinesia, rigidity and postural instability. There are approximately 7–10 million PD …

Parkinson's disease (PD) patients who are carriers of glucosylceramidase β1 (GBA1) gene
mutations typically have an earlier age at onset and a more aggressive disease course, with …

Background In the era of modern medicine, where high‐throughput sequencing techniques
are readily available, it is desirable to elucidate the role of genetic background in patients …

Background Subthalamic deep brain stimulation (STN DBS) may relieve refractory motor
complications in Parkinson's disease (PD) patients. Despite careful screening, it remains …

Deep brain stimulation (DBS) is a widely used clinical therapy that modulates neuronal firing
in subcortical structures, eliciting downstream network effects. Its effectiveness is determined …